Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 33, Issue 12, Pages 13710-13721
Publisher
FASEB
Online
2019-10-05
DOI
10.1096/fj.201901388r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
- (2019) Adele Chimento et al. Frontiers in Endocrinology
- Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic Cancer
- (2018) Nick A. Iarrobino et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Osteocyte-Driven Downregulation of Snail Restrains Effects of Drd2 Inhibitors on Mammary Tumor Cells
- (2018) Shengzhi Liu et al. CANCER RESEARCH
- Breast cancer bone metastases: pathogenesis and therapeutic targets
- (2018) Naomi Brook et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
- (2018) Federica Iannelli et al. Recent Patents on Anti-Cancer Drug Discovery
- Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model
- (2018) Shengzhi Liu et al. Oncotarget
- Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
- (2017) Yusuke Kobayashi et al. Oncotarget
- Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis
- (2017) Kazumasa Minami et al. Scientific Reports
- Rac1/β-Catenin Signalling Pathway Contributes to Trophoblast Cell Invasion by Targeting Snail and MMP9
- (2016) Minghua Fan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Statins for Prevention of Cardiovascular Disease in Adults
- (2016) Roger Chou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins
- (2015) Andy Göbel et al. BREAST CANCER RESEARCH AND TREATMENT
- Suppressed invasive and migratory behaviors of SW1353 chondrosarcoma cells through the regulation of Src, Rac1 GTPase, and MMP13
- (2015) Wenxiao Xu et al. CELLULAR SIGNALLING
- In vitro and in silico analysis of an inhibitory mechanism of osteoclastogenesis by salubrinal and guanabenz
- (2015) Kazunori Hamamura et al. CELLULAR SIGNALLING
- Cancer and the microbiota
- (2015) W. S. Garrett SCIENCE
- Investigation of VOCs associated with different characteristics of breast cancer cells
- (2015) Luca Lavra et al. Scientific Reports
- Urinary Volatile Organic Compounds for the Detection of Prostate Cancer
- (2015) Tanzeela Khalid et al. PLoS One
- In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
- (2014) P Jiang et al. BRITISH JOURNAL OF CANCER
- Volatile organic compound identification and characterization by PCA and mapping at a high-technology science park
- (2014) Cheng-Hang Lan et al. ENVIRONMENTAL POLLUTION
- Statins and breast cancer prognosis: evidence and opportunities
- (2014) Thomas P Ahern et al. LANCET ONCOLOGY
- Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review
- (2014) Edyta Wieczorek et al. TUMOR BIOLOGY
- Volatile Organic Metabolites Identify Patients with Breast Cancer, Cyclomastopathy, and Mammary Gland Fibroma
- (2014) Changsong Wang et al. Scientific Reports
- Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha
- (2013) Kazunori Hamamura et al. JOURNAL OF BONE AND MINERAL METABOLISM
- The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer
- (2012) Ioly Kotta-Loizou et al. Anti-Cancer Agents in Medicinal Chemistry
- Pitavastatin: a different pharmacological profile
- (2012) Alberico L Catapano Clinical Lipidology
- Bisphosphonates for Osteoporosis — Where Do We Go from Here?
- (2012) Marcea Whitaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential binding between volatile ligands and major urinary proteins due to genetic variation in mice
- (2012) Jae Kwak et al. PHYSIOLOGY & BEHAVIOR
- Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts
- (2012) S Ghavami et al. Cell Death & Disease
- The Role of BMPs in Bone Anabolism and their Potential Targets SOST and DKK1
- (2012) Nobuhiro Kamiya Current Molecular Pharmacology
- Algorithms for hierarchical clustering: an overview
- (2011) Fionn Murtagh et al. Wiley Interdisciplinary Reviews-Data Mining and Knowledge Discovery
- Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion
- (2010) Tatsuya Miyazaki et al. ANALYTICAL BIOCHEMISTRY
- Denosumab and bisphosphonates: Different mechanisms of action and effects
- (2010) Roland Baron et al. BONE
- Molecular Targets of the Nitrogen Containing Bisphosphonates: The Molecular Pharmacology of Prenyl Synthase Inhibition
- (2010) J. E. Dunford CURRENT PHARMACEUTICAL DESIGN
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search